TW

DRUG2 trials

Sponsors

Nanjing University School of Medicine

Conditions

Diabetic NephropathyMembranous Nephropathy

Phase 4

To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)

CompletedNCT00518219

Nanjing University School of MedicineMembranous Nephropathy

Start: 2007-07-31End: 2009-09-30Updated: 2010-05-27

Unknown Phase

To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)

CompletedNCT00518362

Nanjing University School of MedicineDiabetic Nephropathy

Start: 2007-07-31End: 2010-03-31Updated: 2010-05-27

Related Papers

Mitochondrial Oxidative Metabolism: An Emerging Therapeutic Target to Improve CKD Outcomes.

2023-05-2911 citations

Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial.

2013-05-3151 citations